Maxim upgraded Adial Pharmaceuticals (ADIL) to Buy from Hold with a $1.50 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADIL:
- Adial Pharmaceuticals Advances AD04 with FDA Support
- Adial announces receipt of final meeting minuts from EOP2 meeting with FDA
- Adial Pharmaceuticals Granted Nasdaq Compliance Extension
- Adial granted a 180 calendar day extension by Nasdaq to regain compliance
- Adial encouraged by U.S. Senate support for extended AUD trial endpoints